However, prospective studies are needed to identify the specific cBA profiles responsible for a potential cause-and-effect relationship with insulin resistance and type 2 diabetes, as well as the mechanism of action of FGF-19, to explore their potential also as targets for novel preventive interventions. This evidence concerns the gene FGF19 and type 2 diabetes mellitus.